Vincenzo Blandino

- Lead, manage, and drive the local performance of Fabhalta (Iptacopan) in Paroxysmal Nocturnal Hemoglobinuria (PNH), ensuring alignment with strategic priorities.

- Act as a key partner within a cross-functional matrix (Medical, Market Access, Marketing) to maximize product adoption and patient impact.

- Build and strengthen long-term relationships with key accounts, gaining deep insights into customer challenges and identifying tailored solutions to improve patient care.

- Implement the tactical business plan at local level, engaging all relevant stakeholders within reference centers in close collaboration with the cross-functional team.

- Ensure execution excellence of strategic and tactical initiatives, contributing to strong uptake of Fabhalta in the first months post-launch, including the activation of key reference centers in line with strategic objectives.

- Played a key role in the pre-launch and launch of three innovative therapies (Kesimpta, Mayzent, Aimovig), contributing to strategic planning and execution at regional level.

- Collaborated within a cross-functional matrix (Medical, Market Access, Marketing) to align on launch priorities and ensure consistent execution across territories.

- Identified and developed key treatment centers, driving patient pathway optimization and supporting access to innovative therapies.

- Built strong, trust-based relationships with key stakeholders, positioning as a partner in addressing clinical and organizational challenges.

- Contributed to achieving and exceeding sales objectives through structured account planning and execution of targeted initiatives.

- Supported the implementation of local projects, training activities, and initiatives aimed at improving team effectiveness and customer engagement, contributing to consistent execution across the region.

- Managed oncology portfolio (breast, lung, hematology, pain), driving commercial performance across the assigned territory.

- Partnered with medical and marketing teams to define and implement customer-centric strategies aligned with business objectives.

- Developed strong relationships with key accounts, understanding clinical needs and contributing to improved patient management.

- Contributed to the successful launch of Entresto (Sacubitril/Valsartan), supporting adoption across key centers in the territory.

- Collaborated cross-functionally to develop and execute commercial strategies, enhancing patient access to innovative therapies.

- Engaged with key stakeholders to support change management and adoption of a first-in-class treatment.

- Promoted products across respiratory (COPD), cardiovascular, and gastroenterology areas, achieving sales targets within the assigned territory.

- Established and developed relationships with healthcare professionals, building a solid customer network.

- Monitored market dynamics and competitor activity, providing insights to support commercial strategy.